An increase in the external TGFβ1 levels may lead to uncontrolled fibrosis, which raises the question of whether a long-term cancer treatment involving betulin and its derivatives that elevate TGFβ1 protein levels is safe. The gene discussed is TGFB1; the disease is cancer.